Discover 134 paid clinical trials in Chattanooga, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 134
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for
Eosinophilic Asthma
Location: Chattanooga TN, East Point GA, Louisville KY,
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07323654
Phase2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Chattanooga TN, Suwanee GA, Tucker GA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Chattanooga TN, Knoxville TN, Atlanta GA, Nashville TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Chattanooga TN, Knoxville TN, Atlanta GA, Nashville TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Chattanooga TN, Knoxville TN, Atlanta GA, Nashville TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Location: Chattanooga TN, Atlanta GA, Knoxville TN, Nashville TN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 5 - 60
Code: NCT05675410
Phase3, Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Chattanooga TN, Knoxville TN, Atlanta GA, Nashville TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Chattanooga TN, Knoxville TN, Atlanta GA, Nashville TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
for
Recurrent or Metastatic Solid Tumors
Location: Chattanooga TN, Nashville TN, Germantown TN, Skokie IL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06330064
Phase1, Phase2, Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Chattanooga TN, Charlotte NC, Winston-Salem NC,
Sponsor: Incyte Corporation
Sex: Female
Age: 18+
Code: NCT07214779
Phase3, Recruiting
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
for
Acute Stroke, Ischemic Stroke, Stroke
Location: Chattanooga TN, Atlanta GA, Greenville SC, Dayton OH,
Sponsor: DiaMedica Therapeutics Inc
Sex: All
Age: 18 - 70+
Code: NCT05065216
Phase2, Phase3, Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
Location: Chattanooga TN, Cincinnati OH, Chapel Hill NC,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07294170
Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Location: Chattanooga TN, Cincinnati OH, Chapel Hill NC,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07284420
Phase2, Recruiting
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
for
Epithelial Ovarian Cancer, Ovarian Cancer,
Location: Chattanooga TN, St Louis MO, New Orleans LA, Orlando FL,
Sponsor: Imunon
Sex: Female
Age: 18+
Code: NCT06915025
Phase3, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)